EARN25

Kickback Accusations Put AbbVie on Track for 4th Straight Loss

The pharmaceutical firm is being accused of providing kickbacks to healthcare providers

Managing Editor
Sep 19, 2018 at 10:09 AM
facebook X logo linkedin


AbbVie Inc (NYSE:ABBV) is in hot water today, after the California Department of Insurance yesterday sued the pharmaceutical name for allegedly providing kickbacks to health insurance providers. The lawsuit accuses AbbVie of providing cash and other gifts to providers that prescribed its arthritis drug Humira. 

While ABBV stock plunged 2.9% on Tuesday in reaction to the news, the shares are down another 0.6% this morning to trade at $91.99. The drop puts ABBV on track for its fourth straight loss, but this negative price action is nothing new. Year-to-date, the security has shed 5.5%, with recent resistance emerging at its 200-day moving average.

Against this backdrop, sentiment is bearish toward AbbVie. Data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows ABBV with a 10-day put/call volume ratio of 1.59, which ranks in the 100th annual percentile. This means that AbbVie puts have been purchased at a faster-than-usual rate relative to calls during the past two weeks.

Plus, of the 15 analysts covering ABBV, 10 maintain a "hold" or worse rating. However, the average 12-month price target for the pharma stock is $109.42 -- a healthy 19% premium to current trading levels. Should the equity continue to struggle, a round of price-target cuts could amplify selling pressure.

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!